Bromelain (pharmacology)

Bromelain, a concentrate of proteolytic enzymes from the pineapple plant, is used in medicine. It is approved in the European Union for the debridement (removal of eschar, that is dead and damaged tissue) of severe burn wounds under the brand name NexoBrid. In the US, it has completed Phase III clinical trials and has the tentative trade name Debrase. It was developed by , Germany; and Teva is responsible for development and marketing in the US. The medicine has been granted orphan drug status by the European Medicines Agency (EMA).

This article is a stub. You can help WikiMD by registering to expand it. Editing is available only to registered and verified users. WikiMD is a comprehensive, free health & wellness encyclopedia.

   This article is a medical stub. You can help WikiMD by expanding it!